DE3889625T2 - Proteolytisches enzym, spezifisch für menschlichen immunmangel-virus, verfahren zu seiner herstellung und renaturierung. - Google Patents

Proteolytisches enzym, spezifisch für menschlichen immunmangel-virus, verfahren zu seiner herstellung und renaturierung.

Info

Publication number
DE3889625T2
DE3889625T2 DE3889625T DE3889625T DE3889625T2 DE 3889625 T2 DE3889625 T2 DE 3889625T2 DE 3889625 T DE3889625 T DE 3889625T DE 3889625 T DE3889625 T DE 3889625T DE 3889625 T2 DE3889625 T2 DE 3889625T2
Authority
DE
Germany
Prior art keywords
hiv
specific
renation
production
proteolytic enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3889625T
Other languages
English (en)
Other versions
DE3889625D1 (de
Inventor
Stephen Oroszlan
Terry Copeland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE3889625D1 publication Critical patent/DE3889625D1/de
Publication of DE3889625T2 publication Critical patent/DE3889625T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3889625T 1987-06-01 1988-06-01 Proteolytisches enzym, spezifisch für menschlichen immunmangel-virus, verfahren zu seiner herstellung und renaturierung. Expired - Fee Related DE3889625T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/057,183 US5252477A (en) 1987-06-01 1987-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
PCT/US1988/001849 WO1988009815A1 (en) 1987-06-01 1988-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Publications (2)

Publication Number Publication Date
DE3889625D1 DE3889625D1 (de) 1994-06-23
DE3889625T2 true DE3889625T2 (de) 1994-09-29

Family

ID=22009015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3889625T Expired - Fee Related DE3889625T2 (de) 1987-06-01 1988-06-01 Proteolytisches enzym, spezifisch für menschlichen immunmangel-virus, verfahren zu seiner herstellung und renaturierung.

Country Status (10)

Country Link
US (2) US5252477A (de)
EP (1) EP0316429B1 (de)
JP (1) JPH02500408A (de)
KR (1) KR890701738A (de)
AT (1) ATE105859T1 (de)
AU (1) AU630590B2 (de)
DE (1) DE3889625T2 (de)
DK (1) DK41289A (de)
FI (1) FI890459A0 (de)
WO (1) WO1988009815A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
US5637488A (en) * 1987-06-01 1997-06-10 The United States Of America As Represented By The Department Of Health And Human Services HIV protease gene and method for its expression
CA1340748C (en) * 1988-07-13 1999-09-14 Stephen Oroszlan Synthetic hiv protease gene and method for its expression
US5147369A (en) * 1991-07-01 1992-09-15 Wagner Michael A Forceps and method for nuclear fragment removal
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
RU2126794C1 (ru) * 1992-03-11 1999-02-27 Нархекс Лимитед Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
AU2377097A (en) 1996-04-30 1997-11-19 Cangene Corporation Antiviral ricin-like proteins
US6531125B1 (en) 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Also Published As

Publication number Publication date
WO1988009815A1 (en) 1988-12-15
DK41289D0 (da) 1989-01-30
JPH02500408A (ja) 1990-02-15
DK41289A (da) 1989-01-30
AU1805188A (en) 1989-01-04
EP0316429A4 (en) 1991-05-22
FI890459A (fi) 1989-01-31
ATE105859T1 (de) 1994-06-15
US5354683A (en) 1994-10-11
EP0316429A1 (de) 1989-05-24
AU630590B2 (en) 1992-11-05
KR890701738A (ko) 1989-12-21
US5252477A (en) 1993-10-12
EP0316429B1 (de) 1994-05-18
FI890459A0 (fi) 1989-01-31
DE3889625D1 (de) 1994-06-23

Similar Documents

Publication Publication Date Title
DE3889625D1 (de) Proteolytisches enzym, spezifisch für menschlichen immunmangel-virus, verfahren zu seiner herstellung und renaturierung.
ATE80657T1 (de) Mischungen von alpha-amylase zur verfluessigung von staerke.
DE69016012T2 (de) Neue hyperthermostabile alpha - amylase.
DE3789881D1 (de) Verfahren zur Herstellung von Photomasken und Photomaske.
DE69941991D1 (de) Verfahren zur Herstellung von L-Aminosäure
DK39693D0 (da) Enzym
KR880000765B1 (en) Process for the preparation of polypetide
DK0909312T3 (da) Fremgangsmåde til fremstilling af polypeptider
HUP9800091A2 (hu) Enzimatikusan aktív rekombináns karboxipeptidáz-B előállítása
DE68912624D1 (de) Membran-Verfahren und System für die Herstellung von Stickstoff.
ATE31077T1 (de) Thermostabile, saure alpha-amylase und verfahren zu ihrer herstellung.
ATE338112T1 (de) Subtilisin dimer mit verbesserter aktivität und verfahren zur herstellung davon.
ATE84074T1 (de) Verfahren zur fermentativen herstellung von 2-(4- hydroxiphenoxi-)propionsaeure.
DK0651791T3 (da) Fremgangsmåde til oprensning af vandig enzymopløsning
ATE109796T1 (de) Gewebeinhibitor für metalloproteasen (timp-2).
ES2018734A6 (es) Procedimiento para la obtencion de un enzima proteolitico.
HUP9801439A2 (hu) Béta-D-Galakotpiranozil-D-xilózok alkalmazása bél laktáz kimutatására alkalmas készítmények és oldatok előállításánál, valamint eljárás a vegyületek előállítására
DE59308942D1 (de) Verfahren zur Bestimmung von Fibrinogen
DE3584593D1 (de) Peroxidase und verfahren zu deren herstellung.
ATE69034T1 (de) Verfahren zur herstellung von polychlorophosphazen.
ATE95188T1 (de) Zellulaere amphipatische proteine in aggregierten formen und verfahren zur herstellung und reinigung diese proteine.
IT1239719B (it) Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv
AR002903A1 (es) Novedosas enzimas proteoliticas.
DE3882654T2 (de) Enzymhemmer und Methode zu dessen Herstellung.
Oroszlan et al. Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee